Teleflex, a US-based firm that provides medical devices for critical care and surgery, has won US FDA 510(k) clearance for its Arrow NextStep retrograde femoral length dialysis catheter.
The catheter adds to the company’s current NextStep hemodialysis catheter portfolio and is intended for ease of insertion and sustained high flow rates.
The company claims that its Arrow NextStep retrograde hemodialysis catheter takes better advantage of the blood flow dynamics within the heart through its reversed port configuration, where the venous port is located in the superior vena cava and the arterial port in the right atrium, resulting in lessened recirculation and high flow rates.
The NextStep Tip is intended for smooth, over-the-wire transitions during catheter insertions and exchanges.
Teleflex Specialty Division president and general manager Linda Beneze said that the Arrow NextStep is the latest in a series of new product introductions that demonstrate the company’s commitment to enhancing patient outcomes and improving ease of use for clinicians.
"We are proud to add the Arrow NextStep retrograde femoral length catheter to our portfolio," Beneze said.